BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26492094)

  • 61. [Cytopathological features of multiple myeloma].
    Takeuchi T; Adachi Y; Ikezoe T; Yokoyama A; Furihata M; Ohtsuki Y
    Nihon Rinsho; 2007 Dec; 65(12):2250-5. PubMed ID: 18069269
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiple myeloma with two rate complications.
    Chugh SN; Girdhar NK; Chopra JS; Singh U; Mahajan SK; Malhotra KC
    J Indian Med Assoc; 1988 Sep; 86(9):246-8. PubMed ID: 3235845
    [No Abstract]   [Full Text] [Related]  

  • 63. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders.
    Menke DM; Greipp PR; Colon-Otero G; Solberg LA; Cockerill KJ; Hook CC; Witzig TE
    Arch Pathol Lab Med; 1994 Aug; 118(8):811-4. PubMed ID: 7520228
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
    Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma cell leukemia. Report on 17 cases.
    Kyle RA; Maldonado JE; Bayrd ED
    Arch Intern Med; 1974 May; 133(5):813-8. PubMed ID: 4821776
    [No Abstract]   [Full Text] [Related]  

  • 66. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Light Chain Myeloma with Highly Atypical Plasma Cells and Extensive Auer Rod-Like Inclusions.
    Enko D; Kriegshäuser G
    Turk J Haematol; 2019 Feb; 36(1):61-62. PubMed ID: 29983403
    [No Abstract]   [Full Text] [Related]  

  • 69. [Primary plasma cell leukemia: about 3 cases].
    Miloudi M; Messaoudi N
    Pan Afr Med J; 2016; 24():167. PubMed ID: 27795764
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation.
    Malysz J; Talamo G; Zhu J; Clarke LE; Bayerl MG; Ali L; Helm KF; Chung CG
    J Am Acad Dermatol; 2016 May; 74(5):878-84. PubMed ID: 26874821
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Solitary and multiple plasmacytoma.
    Kraj M; Maj S; Wroński D; Letowska M
    Acta Med Pol; 1982; 23(1-2):91-103. PubMed ID: 7187604
    [No Abstract]   [Full Text] [Related]  

  • 72. Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases.
    Shah R; Stieltjes B; Andrulis M; Pfeiffer R; Sumkauskaite M; Delorme S; Schlemmer HP; Goldschmidt H; Landgren O; Hillengass J
    Ann Hematol; 2013 Nov; 92(11):1553-7. PubMed ID: 23680869
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia.
    Saini L; Brandwein J; Turner R; Larratt L; Hamilton M; Peters A; Wu C; Zhu N; Taparia M; Patterson JM; Bolster L; Mant M; Ritchie B; Liew E; Mirza I; Quest G; Nahirniak S; Ghosh S; Sandhu I
    Leuk Res; 2016 Jun; 45():47-52. PubMed ID: 27092851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary plasma cell leukaemia.
    Sabharwal BD; Aggarwal SP; Chander K; Duggal A
    J Assoc Physicians India; 1991 May; 39(5):410-1. PubMed ID: 1960162
    [No Abstract]   [Full Text] [Related]  

  • 75. Bence Jones myeloma with signet-ring-like plasma cells.
    Caenazzo A; Sartori D; Poletti A
    Haematologica; 1997; 82(1):122. PubMed ID: 9107097
    [No Abstract]   [Full Text] [Related]  

  • 76. Bortezomib administration with severe hyperbilirubinemia caused by hepatic plasma cell infiltration: a case report.
    Wilson N; Surati M; Walker BF; Kaufman JL; Harvey RD
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):159-61. PubMed ID: 23084405
    [No Abstract]   [Full Text] [Related]  

  • 77. Spontaneous rupture of the spleen on plasma cell leukemia.
    Stephens PJ; Hudson P
    Can Med Assoc J; 1969 Jan; 100(1):31-4. PubMed ID: 4178852
    [No Abstract]   [Full Text] [Related]  

  • 78. Extraosseous extension of multiple myeloma: a cutaneous herald to systemic disease.
    Karimkhani C; Smith C
    J Am Acad Dermatol; 2014 Sep; 71(3):e73-4. PubMed ID: 25128129
    [No Abstract]   [Full Text] [Related]  

  • 79. Monoclonal plasma cell infiltration of eczematous skin in a patient with multiple myeloma.
    Kövary PM; Vakilzadeh F; Intorp HW
    Arch Dermatol Res; 1980; 267(3):323-5. PubMed ID: 7406542
    [No Abstract]   [Full Text] [Related]  

  • 80. Multiple myeloma and secondary plasma cell leukemia.
    Dos Santos VM; Melim SP; de Faria PS; Passini VV; Duarte ML; Casasanta RA
    Rom J Morphol Embryol; 2016; 57(2 Suppl):837-839. PubMed ID: 27833979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.